Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-03-01 @ 3:20 AM
Study NCT ID:
NCT01690702
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2012-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Nab-Paclitaxel in High Risk Early Breast Cancer
Sponsor:
GBG Forschungs GmbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GBG 68
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None